Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease

被引:29
|
作者
Rodriguez-Morato, Jose [1 ,2 ,3 ]
Matthan, Nirupa R. [4 ]
机构
[1] Hosp del Mar, IMIM, Integrat Pharmacol & Syst Neurosci Res Grp, Med Res Inst, Doctor Aiguader 88, Barcelona 08003, Spain
[2] Inst Salud Carlos III, Spanish Biomed Res Ctr Physiopathol Obes & Nutr C, Madrid 28029, Spain
[3] Univ Pompeu Fabra CEXS UPF, Dept Expt & Hlth Sci, Dr Aiguader 80, Barcelona 08003, Spain
[4] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Cardiovasc Nutr Lab, 711 Washington St, Boston, MA 02111 USA
基金
欧盟地平线“2020”;
关键词
Diet; Bile acids; Gut microbiota; Cardiometabolic risk factors; Cardiovascular disease; Metabolism; GUT MICROBIOTA; INTESTINAL MICROBIOTA; NUCLEAR RECEPTOR; HEALTHY-ADULTS; RISK-FACTORS; FOLLOW-UP; HIGH-FAT; CHOLESTEROL; METABOLISM; SERUM;
D O I
10.1007/s11883-020-00863-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review The goal is to review the connection between gut microbiota and cardiovascular disease, with specific emphasis on bile acids, and the influence of diet in modulating this relationship. Recent Findings Bile acids exert a much broader range of biological functions than initially recognized, including regulation of cardiovascular function through direct and indirect mechanisms. There is a bi-directional relationship between gut microbiota modulation of bile acid-signaling properties, and their effects on gut microbiota composition. Evidence, primarily from rodent models and limited human trials, suggest that dietary modulation of the gut microbiome significantly impacts bile acid metabolism and subsequently host physiological response(s). Available evidence suggests that the link between diet, gut microbiota, and CVD risk is potentially mediated via bile acid effects on diverse metabolic pathways. However, further studies are needed to confirm/expand and translate these findings in a clinical setting.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease
    Jose Rodríguez-Morató
    Nirupa R. Matthan
    Current Atherosclerosis Reports, 2020, 22
  • [2] Protecting liver health with microbial-derived succinylated bile acids
    Demagny, Hadrien
    Perino, Alessia
    Schoonjans, Kristina
    LIFE METABOLISM, 2024, 3 (05):
  • [3] Protecting liver health with microbial-derived succinylated bile acids
    Hadrien Demagny
    Alessia Perino
    Kristina Schoonjans
    Life Metabolism, 2024, 3 (05) : 13 - 16
  • [4] Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
    Winston, Jenessa A.
    Theriot, Casey M.
    ANAEROBE, 2016, 41 : 44 - 50
  • [5] Gut microbiota-derived secondary bile acids, bile acids receptor polymorphisms, and risk of cardiovascular disease in individuals with newly diagnosed type 2 diabetes: a cohort study
    Lu, Qi
    Chen, Junxiang
    Jiang, Limiao
    Geng, Tingting
    Tian, Shufan
    Liao, Yunfei
    Yang, Kun
    Zheng, Yan
    He, Meian
    Tang, Huiru
    Pan, An
    Liu, Gang
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2024, 119 (02): : 324 - 332
  • [6] Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
    Kouhzad, Mobina
    Goetz, Friedrich
    Navidifar, Tahereh
    Taki, Elahe
    Ghamari, Mahsa
    Mohammadzadeh, Roghayeh
    Seyedolmohadesin, Maryam
    Bostanghadiri, Narjess
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [7] A microbial-derived succinylated bile acid to safeguard liver health
    Perino, Alessia
    Demagny, Hadrien
    Schoonjans, Kristina
    CELL, 2024, 187 (11) : 2687 - 2689
  • [8] Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
    Yang, Rong
    Qian, Li
    INTEGRATIVE CANCER THERAPIES, 2022, 21
  • [9] Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
    Yang, Rong
    Qian, Li
    INTEGRATIVE CANCER THERAPIES, 2022, 21
  • [10] Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease
    Blake, Amanda B.
    Guard, Blake C.
    Honneffer, Julia B.
    Lidbury, Jonathan A.
    Steiner, Jorg M.
    Suchodolski, Jan S.
    PLOS ONE, 2019, 14 (10):